SII Sees Demand Doubling In Five Years
Pune: Serum Institute of India Pvt. is expanding its production capacity as it expects sales of life-saving vaccines, including those for malaria and cervical cancer, to double in the next five…
Lupin Recalls 51k Bottles Of Generic Antibiotic Drug In US
New Delhi: Drug firm Lupin is recalling over 51,000 bottles of a generic antibiotic medication in the U.S. market due to a “defective container”, according to the American health regulator.…
NDLEA Intercepts Another Shipment Of Codeine From India
Lagos: The recent interception of 175,000 bottles of opioids imported from India by the National Drug Law Enforcement Agency (NDLEA) comes shortly after the seizure of a similar shipment at…
RGHS: Doorstep Drug Delivery Now Within 24 Hrs In City
Jaipur: The state govt on Sunday issued revised guidelines to simplify the process of doorstep delivery of drugs and medicines under Rajasthan government health scheme (RGHS). Under the new guidelines,…
In probe prompted by NICU fire, Delhi ACB finds 40 nursing homes violating fire safety norms
New Delhi: Weeks after a deadly fire at a neonatal intensive care unit (NICU) claimed the lives of seven newborns in Delhi’s Shahdara district, the anti-corruption branch (ACB) found four nursing…
CDSCO panel gives nod for continuation of phase-II clinical trial of SII’s dengue vaccine
New Delhi: An expert committee under the Central Drug Regulatory Authority has recommended continuation of phase II clinical trial of the Serum Institute Of India (SII)’s vaccine against dengue after…
CBI To Probe Ex-Assistant Drugs Controller Misconduct: High Court
New Delhi: In a significant development, the High Court of Punjab and Haryana has directed the Central Bureau of Investigation (CBI) to take over the investigation of a case involving…
FoPE Raises Concerns Over New Schedule M’s Impact On Cosmetic Manufacturing
New Delhi: The pharmaceutical industry has raised concerns regarding the government’s newly notified schedule M that proposes a blanket ban on manufacture of any other article or product apart from drugs…
US FDA Warns On Risks Linked To Sulfite-Containing Compounded Drugs
London: The U.S. Food and Drug Administration said on Wednesday it had alerted healthcare professionals, drug compounders and patients about the risk of allergic reactions to sulfite-containing compounded drugs. The FDA said it…
PLI Scheme For Medical Devices Attracts Investment Of Rs. 959 Crore Till April 2024
New Delhi: The production linked incentive (PLI) scheme for medical devices has reported commissioning of 17 manufacturing units till the end of April, 2024, with an actual investment of around…
